Abstract:Protein inhibitor of activated STAT1 (PIAS1), a small ubiquitin-like modifier (SUMO) E3 ligase, was considered to be an inhibitor of STAT1 by inhibiting the DNA-binding activity of STAT1 and blocking STAT1-mediated gene transcription in response to cytokine stimulation. PIAS1 has been determined to be involved in modulating several biological processes such as cell proliferation, DNA damage responses, and inflammatory responses, both in vivo and in vitro. However, the role played by PIAS1 in regulating neurodegenerative diseases, including Alzheimer’s disease (AD), has not been determined. In our study, significantly different expression levels of PIAS1 between normal controls and AD patients were detected in four regions of the human brain. Based on a functional analysis of Pias1 in undifferentiated mouse hippocampal neuronal HT-22 cells, we observed that the expression levels of several AD marker genes could be inhibited by Pias1 overexpression. Moreover, the proliferation ability of HT-22 cells could be promoted by the overexpression of Pias1. Furthermore, we performed RNA sequencing (RNA-seq) to evaluate and quantify the gene expression profiles in response to Pias1 overexpression in HT-22 cells. As a result, 285 significantly dysregulated genes, including 79 upregulated genes and 206 downregulated genes, were identified by the comparison of Pias1/+ cells with WT cells. Among these genes, five overlapping genes, including early growth response 1 (Egr1), early growth response 2 (Egr2), early growth response 3 (Egr3), FBJ osteosarcoma oncogene (Fos) and fos-like antigen 1 (Fosl1), were identified by comparison of the transcription factor binding site (TFBS) prediction results for STAT1, whose expression was evaluated by qPCR. Three cell cycle inhibitors, p53, p18 and p21, were significantly downregulated with the overexpression of Pias1. Analysis of functional enrichment and expression levels showed that basic region leucine zipper domain-containing transcription factors including zinc finger C2H2 (zf-C2H2), homeobox and basic/helix-loop-helix (bHLH) in several signaling pathways were significantly involved in PIAS1 regulation in HT-22 cells. A reconstructed regulatory network under PIAS1 overexpression demonstrated that there were 43 related proteins, notably Nr3c2, that directly interacted with PIAS1.

Protein phosphatase-2A inhibitor-2 up-regulates p53 and Akt-implication for a new mechanism for Alzheimer's neurodegeneration

IC‐P‐100: Protein Phosphatase‐2a Inhibitor‐2 Up‐regulates P53 and Akt‐implication for a New Mechanism for Alzheimer Neurodegeneration

I2 PP2A Regulates P53 and Akt Correlatively and Leads the Neurons to Abort Apoptosis

Activation of Glycogen Synthase Kinase-3 Inhibits Protein Phosphatase-2A and the Underlying Mechanisms

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Silencing I-2(Pp2a) Rescues Tau Pathologies And Memory Deficits Through Rescuing Pp2a And Inhibiting Gsk-3 Beta Signaling In Human Tau Transgenic Mice

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.

Silencing PP2A Inhibitor by Lenti-Shrna Interference Ameliorates Neuropathologies and Memory Deficits in Tg2576 Mice.

PTPA Activates Protein Phosphatase-2A Through Reducing Its Phosphorylation at Tyrosine-307 with Upregulation of Protein Tyrosine Phosphatase 1B.

Upregulation of Astrocytes Protein Phosphatase‐2a Stimulates Astrocytes Migration Via Inhibiting P38 MAPK in Tg2576 Mice

Prostaglandin I2 upregulates the expression of anterior pharynx‐defective‐1α and anterior pharynx‐defective‐1β in amyloid precursor protein/presenilin 1 transgenic mice

P53-Dependent Control of Transactivation of the Pen2 Promoter by Presenilins

Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

PP2A Subunit PPP2R2C is Downregulated in the Brains of Alzheimer's Transgenic Mice.

P1‐295: Mimic Phosphorylation of SET at Ser 9 Promotes an Inhibition of PP2A

Functional Genomics Study of Protein Inhibitor of Activated STAT1 in Mouse Hippocampal Neuronal Cells Revealed by RNA Sequencing

Inhibitor of apoptosis stimulating protein of p53 protects against MPP+-induced neurotoxicity of dopaminergic neurons

Inhibition of PTEN Attenuates Endoplasmic Reticulum Stress and Apoptosis Via Activation of PI3K/AKT Pathway in Alzheimer’s Disease

Pirh2 modulates the mitochondrial function and cytochrome c-mediated neuronal death during Alzheimer's disease